Welcome to #NephMadness 2026
Our beautiful baby has grown into a moody, hormonal teen. That’s right, it’s year 14 of NephMadness! Whether this is your first time or you are a seasoned [...]
Yau
#NephMadness 2026: Blue Ribbon Panel
NephMadness 2026 starts in just over a month! Sixteen teams will battle it out for the title, and a new champion will be crowned. But who actually chooses the winners and [...]
Phosphorus, Tenapanor, and Vitamin Water?: An Interview
Hyperphosphatemia remains a major challenge in managing patients with kidney failure and is associated with significant morbidity and mortality. In a Mini-Review recently [...]
CKD and Inflammation: An Interview
Chronic systemic inflammation, triggered by innate immune system activation, is a key driver of both chronic kidney disease (CKD) and associated atherosclerosis and [...]
Patient Perspectives on Living with Membranous Nephropathy: An Interview
Membranous nephropathy (MN) is characterized by a relapsing remitting course with a third of patients developing kidney failure if untreated. A recent study published in AJKD [...]
GLP1 Receptor Agonists vs SGLT2-I in Preventing CKD in T2DM: An Interview
Glucagon-like peptide-1 receptor agonists and sodium/glucose cotransporter 2 (SGLT2) inhibitors can improve outcomes in patients with type 2 diabetes. Using a nationwide [...]
Kidney Transplant Outcomes Among Hispanic Recipients: An Interview
Hispanics, the largest ethnic minority group in the United States, experience faster progression of chronic kidney disease to kidney failure compared with non-Hispanic White [...]
Quantifying Proteinuria: An Interview
Proteinuria plays a central role in the diagnosis of kidney disease and has a high prognostic value. The test methods used differ considerably regarding their impact on test [...]
Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD): An Interview
Autosomal-dominant polycystic kidney disease (ADPKD) is a chronic systemic disease that affects all races and ethnicities. During the past decade, more evidence has emerged [...]
Statin Use in Chronic Kidney Disease: An Interview
Chronic kidney disease (CKD) populations face an elevated risk of cardiovascular disease (CVD), yet many remain undertreated with statins for primary prevention of CVD [...]